Rating History for AstraZeneca (AZN) by BNP Paribas Exane
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/15/2025 | N/A | New Coverage | Outperform (N/A) |
75.00 (N/A) |
68.01 (92.77) |
36.41% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/15/2025 | N/A | New Coverage | Outperform (N/A) |
75.00 (N/A) |
68.01 (92.77) |
36.41% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||